§ 13F · FUND PROFILE
MPM BIOIMPACT LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 38Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$874.0T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | CGEM | Cullinan Therapeutics, Inc. | 7.65M | $79.2T | 9.1% | NEW |
| 2 | MDGL | Madrigal Pharmaceuticals Inc | 97K | $56.4T | 6.4% | NEW |
| 3 | LQDA | Liquidia Corp | 1.40M | $48.3T | 5.5% | NEW |
| 4 | TRVI | Trevi Therapeutics Inc | 3.29M | $41.2T | 4.7% | NEW |
| 5 | EWTX | Edgewise Therapeutics Inc | 1.66M | $41.1T | 4.7% | NEW |
| 6 | RVMD | Revolution Medicines, Inc. | 506K | $40.3T | 4.6% | NEW |
| 7 | AGIO | Agios Pharmaceuticals Inc | 1.30M | $35.5T | 4.1% | NEW |
| 8 | QURE | Uniqure NV | 1.38M | $33.1T | 3.8% | NEW |
| 9 | PTCT | PTC Therapeutics Inc | 430K | $32.7T | 3.7% | NEW |
| 10 | SNDX | Syndax Pharmaceuticals Inc | 1.34M | $28.1T | 3.2% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE MPM SIGNAL
AC read
MPM BIOIMPACT LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed